Defining proteostasis networks in axon segments

定义轴突段中的蛋白质稳态网络

基本信息

  • 批准号:
    10493637
  • 负责人:
  • 金额:
    $ 37.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-01 至 2027-04-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Neurodegenerative disorders represent a significant challenge to human health. Many therapeutic strategies revolve around suppressing death of the neuronal cell body. However, neuronal connectivity depends on long projections called axons that use specialized mechanisms to survive in isolation from the soma. The degeneration of axons is a common, sometimes initiating event in a variety of neurodegenerative disorders including Alzheimer’s disease, Parkinson’s disease, and peripheral neuropathies. Protecting axon health is necessary for sustaining functional connectivity and will have broad relevance to many diseases. In the aging nervous system there is a well-documented decline in protein homeostasis and accumulation of protein aggregates that threaten neuronal function. Protein homeostasis is predominantly studied in context of the neuronal cell body. However, axons are also susceptible because protein aggregates interfere with transport and disrupt synaptic function. Polypeptides are most vulnerable to misfolding and aggregation as they exit the ribosome. Axons locally synthesize many proteins needed for survival however there is a gap in knowledge regarding basic mechanisms that protect axons from protein misfolding. This project will determine the capacity of axon segments to resist protein misfolding and aggregation. We will also determine the preferred mechanisms used within axon segments for degrading non-native polypeptides and disposing of aggregates. NAD+ levels decline as we age and this project will identify the consequences local NAD+ depletion on protein homeostasis within the axon compartment. Altogether, this project will generate new insight on local mechanisms controlling axon health and reveal treatment opportunities in neurodegenerative disorders.
项目摘要/摘要 神经退行性疾病是对人类健康的重大挑战。许多治疗策略 围绕抑制神经元细胞体的死亡。但是,神经元连通性取决于长时间 称为轴突的项目,使用专门的机制与Soma隔离生存。 轴突的变性是在多种神经退行性疾病中常见的,有时是启动的事件 包括阿尔茨海默氏病,帕金森氏病和周围神经病。保护轴突健康是 维持功能连通性所必需的,并将广泛释放到许多疾病中。在衰老中 神经系统蛋白质稳态有充分记录的下降和蛋白质的积累 汇总了威胁神经元功能的汇总。蛋白质稳态主要是在 神经元细胞体。但是,轴突也很易感,因为蛋白质聚集了干扰转运 并破坏突触功能。当多肽退出时,多肽最容易折叠和聚集 核糖体。轴突本地合成生存所需的许多蛋白质 考虑保护轴突免受蛋白质折叠折叠的基本机制。该项目将确定能力 轴突段以抵抗蛋白质错误折叠和聚集。我们还将确定首选 轴突段内使用的机制可降解非本地多肽和骨料处置。 随着年龄的增长,NAD+水平下降,该项目将确定局部NAD+部署的后果 轴突室内的稳态。总之,该项目将对本地产生新的见解 控制轴突健康的机制并揭示了神经退行性疾病的治疗机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel Summers其他文献

Daniel Summers的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel Summers', 18)}}的其他基金

Defining proteostasis networks in axon segments
定义轴突段中的蛋白质稳态网络
  • 批准号:
    10626162
  • 财政年份:
    2022
  • 资助金额:
    $ 37.37万
  • 项目类别:
Identifying mechanisms that regulate local axon vulnerability to pathological degeneration
识别调节局部轴突易受病理变性影响的机制
  • 批准号:
    10563209
  • 财政年份:
    2022
  • 资助金额:
    $ 37.37万
  • 项目类别:
Identifying mechanisms that regulate local axon vulnerability to pathological degeneration
识别调节局部轴突易受病理变性影响的机制
  • 批准号:
    10415770
  • 财政年份:
    2022
  • 资助金额:
    $ 37.37万
  • 项目类别:

相似海外基金

Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
  • 批准号:
    10817516
  • 财政年份:
    2023
  • 资助金额:
    $ 37.37万
  • 项目类别:
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
宿主与 SARS-CoV-2 之间的战斗中病毒基因调控的新机制
  • 批准号:
    10725416
  • 财政年份:
    2023
  • 资助金额:
    $ 37.37万
  • 项目类别:
Glia Exclusive Gene Therapy
胶质细胞独家基因疗法
  • 批准号:
    10739502
  • 财政年份:
    2023
  • 资助金额:
    $ 37.37万
  • 项目类别:
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
  • 批准号:
    10750357
  • 财政年份:
    2023
  • 资助金额:
    $ 37.37万
  • 项目类别:
Development of Utrophin Site Blocking Oligos (SBOs) to Treat Duchenne Muscular Dystrophy (DMD)
开发 Utropin 位点封闭寡核苷酸 (SBO) 来治疗杜氏肌营养不良症 (DMD)
  • 批准号:
    10678195
  • 财政年份:
    2023
  • 资助金额:
    $ 37.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了